These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26122229)

  • 21. Effects of Vitamin D3 on Intestinal Flora in a Mouse Model of Inflammatory Bowel Disease Treated with Rifaximin.
    Gu Z; Duan M; Sun Y; Leng T; Xu T; Gu Y; Gu Z; Lin Z; Yang L; Ji M
    Med Sci Monit; 2020 Nov; 26():e925068. PubMed ID: 33177483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diethylstilbestrol-scaffold-based pregnane X receptor modulators.
    Hodnik Ž; Tomašič T; Smodiš D; D'Amore C; Mašič LP; Fiorucci S; Kikelj D
    Eur J Med Chem; 2015 Oct; 103():551-62. PubMed ID: 26408814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis.
    Fiorucci S; Distrutti E; Mencarelli A; Barbanti M; Palazzini E; Morelli A
    Digestion; 2002; 66(4):246-56. PubMed ID: 12592101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.
    Li T; Chiang JY
    Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition.
    Rosette C; Agan FJ; Rosette N; Moro L; Mazzetti A; Hassan C; Gerloni M
    Drug Metab Pharmacokinet; 2019 Jun; 34(3):172-180. PubMed ID: 31101589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifaximin in the treatment of inflammatory bowel disease.
    Guslandi M
    World J Gastroenterol; 2011 Nov; 17(42):4643-6. PubMed ID: 22180705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Rifaximin in Inflammatory Bowel Disease Treatment.
    Scribano ML
    Mini Rev Med Chem; 2015; 16(3):225-9. PubMed ID: 26202194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifaximin: a nonabsorbed oral antibiotic.
    Baker DE
    Rev Gastroenterol Disord; 2005; 5(1):19-30. PubMed ID: 15741929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors.
    Gupta A; Mugundu GM; Desai PB; Thummel KE; Unadkat JD
    Drug Metab Dispos; 2008 Jun; 36(6):1172-80. PubMed ID: 18332086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
    Kothary V; Scherl EJ; Bosworth B; Jiang ZD; Dupont HL; Harel J; Simpson KW; Dogan B
    Antimicrob Agents Chemother; 2013 Feb; 57(2):811-7. PubMed ID: 23183443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo responses of the human and murine pregnane X receptor to dexamethasone in mice.
    Scheer N; Ross J; Kapelyukh Y; Rode A; Wolf CR
    Drug Metab Dispos; 2010 Jul; 38(7):1046-53. PubMed ID: 20354104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids.
    de Wit K; Beuers U; Mukha A; Stigter ECA; Gulersonmez MC; Ramos Pittol JM; Middendorp S; Takkenberg RB; van Mil SWC
    Liver Int; 2023 Mar; 43(3):649-659. PubMed ID: 36463417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease.
    Lopetuso LR; Napoli M; Rizzatti G; Gasbarrini A
    Expert Opin Investig Drugs; 2018 Jun; 27(6):543-551. PubMed ID: 29865875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the Molecular Mechanisms of Rifaximin in the Treatment of Gastrointestinal Disorders--A Focus on the Modulation of Host Tissue Function.
    Hirota SA
    Mini Rev Med Chem; 2015; 16(3):206-17. PubMed ID: 26202186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach.
    Gionchetti P; Rizzello F; Venturi A; Ugolini F; Rossi M; Brigidi P; Johansson R; Ferrieri A; Poggioli G; Campieri M
    Eur Rev Med Pharmacol Sci; 1999; 3(1):27-30. PubMed ID: 10710827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study comparing the efficacy of antimicrobial agents versus enzyme (P-gp) inducers in the treatment of 2,4,6 trinitrobenzenesulfonic acid-induced colitis in rats.
    Toklu HZ; Kabasakal L; Imeryuz N; Kan B; Celikel C; Cetinel S; Orun O; Yuksel M; Dulger GA
    J Physiol Pharmacol; 2013 Aug; 64(4):439-51. PubMed ID: 24101390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction: understanding mechanisms of the actions of rifaximin in selected gastrointestinal diseases.
    DuPont HL
    Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():1-2. PubMed ID: 26618920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in Gene Regulation by Dual Ligands of Nuclear Receptors Constitutive Androstane Receptor (CAR) and Pregnane X Receptor (PXR) in HepG2 Cells Stably Expressing CAR/PXR.
    Kanno Y; Tanuma N; Yazawa S; Zhao S; Inaba M; Nakamura S; Nemoto K; Inouye Y
    Drug Metab Dispos; 2016 Aug; 44(8):1158-63. PubMed ID: 27197997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
    Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
    Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifamycins, Alone and in Combination.
    Rothstein DM
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27270559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.